绿新生物科技(01084)发布中期业绩股东应占亏损139.2万元同比减少88.47%

智通财经08-31

智通财经APP讯，绿新生物科技(01084)发布截至2026年6月30日止六个月业绩，该集团期内收益为5.35亿元，同比增长30.45%。公司拥有人应占亏损139.2万元，同比减少88.47%;每股亏损0.002元。于2026年上半年，收益增加主要归因于所有主要类型亲水胶体产品的收益增加，主要由于就精制卡拉胶的销售实施价格主导的销售策略;及期内市场动态及集团其他亲水胶体产品的成本效益所带动的需求...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2663016370?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-08-31 22:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2663016370","market":"sh","top_or_hot":-1,"title":"绿新生物科技(01084)发布中期业绩 股东应占亏损139.2万元 同比减少88.47%","media":"智通财经","content":"<div>\n<p>智通财经APP讯，绿新生物科技(01084)发布截至2026年6月30日止六个月业绩，该集团期内收益为5.35亿元，同比增长30.45%。公司拥有人应占亏损139.2万元，同比减少88.47%;每股亏损0.002元。于2026年上半年，收益增加主要归因于所有主要类型亲水胶体产品的收益增加，主要由于就精制卡拉胶的销售实施价格主导的销售策略;及期内市场动态及集团其他亲水胶体产品的成本效益所带动的需求...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1489956.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>绿新生物科技(01084)发布中期业绩 股东应占亏损139.2万元 同比减少88.47%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n绿新生物科技(01084)发布中期业绩 股东应占亏损139.2万元 同比减少88.47%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-08-31 22:34 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1489956.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，绿新生物科技(01084)发布截至2026年6月30日止六个月业绩，该集团期内收益为5.35亿元，同比增长30.45%。公司拥有人应占亏损139.2万元，同比减少88.47%;每股亏损0.002元。于2026年上半年，收益增加主要归因于所有主要类型亲水胶体产品的收益增加，主要由于就精制卡拉胶的销售实施价格主导的销售策略;及期内市场动态及集团其他亲水胶体产品的成本效益所带动的需求...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1489956.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01084","symbol_name":"绿新生物科技","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1489956.html","article_id":"2663016370","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2663016370","pubTimestamp":1788186896,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，绿新生物科技(01084)发布截至2026年6月30日止六个月业绩，该集团期内收益为5.35亿元，同比增长30.45%。公司拥有人应占亏损139.2万元，同比减少88.47%;每股亏损0.002元。于2026年上半年，收益增加主要归因于所有主要类型亲水胶体产品的收益增加，主要由于就精制卡拉胶的销售实施价格主导的销售策略;及期内市场动态及集团其他亲水胶体产品的成本效益所带动的需求增长，使销量增加。卡拉胶及琼脂产品的总收益占集团总收益的 76.1%，较2025年上半年轻微增加0.3%。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"01084":"绿新生物科技","BK1129":"特种化学制品"},"translate_title":"Green New Biotechnology (01084) released its interim results, reporting a loss attributable to shareholders of RMB 1.392 million, a year-on-year decrease of 88.47%.","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01084":1.5},"content_text":"智通财经APP讯，绿新生物科技(01084)发布截至2026年6月30日止六个月业绩，该集团期内收益为5.35亿元，同比增长30.45%。公司拥有人应占亏损139.2万元，同比减少88.47%;每股亏损0.002元。于2026年上半年，收益增加主要归因于所有主要类型亲水胶体产品的收益增加，主要由于就精制卡拉胶的销售实施价格主导的销售策略;及期内市场动态及集团其他亲水胶体产品的成本效益所带动的需求增长，使销量增加。卡拉胶及琼脂产品的总收益占集团总收益的 76.1%，较2025年上半年轻微增加0.3%。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2663016370","isCrawlerRequest":true}

绿新生物科技(01084)发布中期业绩 股东应占亏损139.2万元 同比减少88.47%

精彩评论

绿新生物科技(01084)发布中期业绩股东应占亏损139.2万元同比减少88.47%